SCHEMBL8005705

SCHEMBL8005705

C[C@]12C[C@@H](c3ccccn3)C(=O)C=C1CCC1C2CC[C@@]2(C)C1CC[C@@H]2C(=O)S

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 8/20 0.48
CYP3A4 P08684 7/20 0.48
ALDH1A1 P00352 6/20 0.48
SMN1; SMN2 Q16637 5/20 0.48
MAPT P10636 5/20 0.48
MAPK1 P28482 4/20 0.48
TSHR P16473 4/20 0.48
SHBG P04278 4/20 0.48
SERPINA6 P08185 4/20 0.48
NR3C1 P04150 4/20 0.48
PGR P06401 4/20 0.48
AR P10275 3/20 0.48
GPBAR1 Q8TDU6 3/20 0.48
SIGMAR1 Q99720 3/20 0.48
CYP2C9 P11712 2/20 0.48
HIF1A Q16665 2/20 0.48
ABCB11 O95342 2/20 0.48
NR3C2 P08235 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11496789 0.79 CYP3A4 (0.53) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL7755258 0.77 SRD5A1 (0.46) AR
SCHEMBL8894380 0.77 SRD5A1 (0.46) AR
SCHEMBL8804307 0.75 LMNA (0.81) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL23748331 0.71 CYP3A4 (0.71) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL11152503 0.71 CYP19A1 (0.65) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL9640298 0.71 SMN1; SMN2 (0.71) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL6053061 0.71 CYP19A1 (0.66) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL674222 0.71 CYP3A4 (0.71) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL9528950 0.71 ALDH1A1 (0.58) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0858455-A4 4-OXA AND 4-THIA STEROIDS MERCK & CO INC (US) 2000-04-12 EP disclosed
US-5998464-A 4-Oxa and 4-thia steroids MERCK & CO., INC. (US) 1999-12-07 US disclosed
US-5932559-A Treatment of hyperandrogenic conditions MERCK & CO., INC. (US) 1999-08-03 US disclosed
EP-0858455-A1 4-OXA AND 4-THIA STEROIDS Merck & Co., Inc. (US) 1998-08-19 EP disclosed
US-5777134-A 4-oxa and 4-thia steriods MERCK & CO., INC. (US) 1998-07-07 US disclosed
US-5756480-A Treatment of hyperandrogenic conditions MERCK & CO., INC. (US) 1998-05-26 US disclosed
WO-1997015305-A1 TREATMENT OF HYPERANDROGENIC CONDITIONS MERCK & CO., INC. (US) 1997-05-01 WO disclosed
WO-1997015564-A1 4-OXA AND 4-THIA STEROIDS MERCK & CO., INC. (US) 1997-05-01 WO disclosed